Key Drivers
- Strong Liquidity
- Solid Cash Flow
- Thin Profitability
AIAI Summary
RGEN has shifted from a simple growth story to a “prove the earnings power” setup: strong free cash flow, liquidity, and margin improvement support the stock, but moderated growth guidance and a still-rich valuation mean the next leg higher depends on sustained organic reacceleration and clearer operating leverage.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong Liquidity
- •Solid Cash Flow
- •Thin Profitability
RGEN shows strong liquidity, manageable leverage, and solid free cash flow, but modest profitability, thin quarterly interest coverage, heavy intangibles, and a demanding valuation limit the upside.
Price Behavior
Key Price Behavior Insights:
- •Higher lows
- •Breakout follow-through
- •Stretched rally
RGEN has been in a constructive uptrend over the last month, with a breakout to $147.01 signaling buyer strength, but it looks stretched near term and needs to hold above roughly $136-$137 to keep the bullish setup intact.
Sharp drop from $147.01 to $136.44 showed quick reversal risk
Sentiment & News
Key News Insights:
- •Volatile Price Swings
- •Strong GF Score
- •Below GF Value
Repligen saw choppy June trading with sharp swings but stayed within its 52-week range and below GF Value, suggesting valuation support despite no new operating catalyst.
The headline-driven moves appear to reflect sentiment and valuation re-rating more than business fundamentals, leaving near-term direction dependent on broader market momentum
Similar Companies in Healthcare
Other companies in the same sector with AI ratings